Ischemic stroke during cisplatin-based chemotherapy for testicular germ cell tumor: Case report and review of the literature

Journal of Chemotherapy

Volumn 22, Issue 2, 2010, Pages 134-136

  Meattini, Icro ^a   Scotti, V ^a   Pescini, F ^a   Livi, L ^a   Sulprizio, S ^a   Palumbo, V ^a   Sarti, C ^a   Bitt, G ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cerebrovascular accident; Chemotherapy; Cisplatin; Ischemic stroke; Testicular germ cell neoplasms

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; ETOPOSIDE; RECOMBINANT PLASMINOGEN ACTIVATOR;

ADULT; APHASIA; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING TEST; BLOOD PRESSURE MONITORING; CANCER INVASION; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; GERM CELL TUMOR; HEMIPLEGIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG FUNCTION TEST; MALE; MULTIPLE CYCLE TREATMENT; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NON SEMINOMATOUS GERM CELL TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; ORCHIECTOMY; POSITRON EMISSION TOMOGRAPHY; TREATMENT OUTCOME;

EID: 77951544007     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2010.22.2.134     Document Type: Article

References (30)

1. Krege S, Souchon R. Schmoll HJ. German Testicular Cancer Study Group. Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: Result of an update conference on evidence-based medicine (EBM). Eur Urol 2001; 40:372-391
2. Bosl GJ, Bajorin DF, Sheinfeld J. Cancer of the testis. In: DeVita VT, I Iellman S, Rosenberg SA, eds. Cancer: principles & practice of oncology, 6th edn. Philadelphia: Lippincott Williams & Wilkins, 2001: 1491-1518
3. Saxman SB, Finch D, Gonin R, Einhom LH. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience. J Clin Oncol 1998; 16:702-706
4. Azak A, Oksüzo lu B, Deren T, Onaç BM, Zengin N. Cerebrovascular accident during cisplatin-based combination chemotherapy of testicular germ cell tumor: an unusual case report. Anticancer Drugs 2008; 19:97-98
5. Wahlgren N, Ahmed N. Dávalos A. Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-282.
6. th edn. New York: Wiley-Liss, 2002.
7. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Horwich A, et al. Guidelines on testicular cancer. Eur Urol 2005; 48:885-894
8. Pont J, Albrecht W, Postner G, Sellner F, Angel K, Höltl W. Adjuvant chamotharapy for high-risk clinical stage I nonseminomatous testicular germ call cancer: long-term results of a prospective trial. J Clin Oncol 1996; 14:441-448
9. Oliver RT, Raja MA, Ong J, Gallagher CJ. Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients. J Urol 1992; 148:1453-1455
10. BosI GJ, Leitner SP, Atlas SA, Sealey JE, Preibisz JJ, Scheiner E. Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors. J Clin Oncol 1986; 4: 1684-1689
11. Hansen SW, Helweg-Larsen S, Trojaborg W. Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for matastatic germ cell cancer. J Clin Oncol 1989; 7:1457-61.
12. Dirix LY, Libura M, Libura J, et al: In vitro toxicity studies with mitomycins and bleomycin on endothelial cells. Anticancer Drugs 1997; 8: 859-868.
13. Weijl NI, Rutten MF, Zwinderman AH, Keizar HJ, Nooy MA, Rosendaal FR, et al. Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and raview of the literature. J Clin Oncol 2000; 18: 2169-2178
14. Gerl A. Vascular toxicity associated with chemotherapy for testicular cancer. Anticancer Drugs 1994; 5:607-614 (Pubitemid 24381877)
15. Doll DC, List AF, Greco A, Hainsworth JD, Hande KR, Johnson DH. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann Intern Med 1986; 105:48-51.
16. El Amrani M, Heinzlef O, Debroucker T, Roullet É. Bousser MG, Amarenco P. Brain infarction following 5-fluoracill and cisplatin therapy. Neurology 1998: 51:899-901.
17. Hennessy B, O'Connor M, Carney DN. Acute vascular events associated with cisplatin tharapy in malignant disease. Ir Med J 2002; 95:145-148
18. Gerl A, Clemm C, Wilmanns W. Acute cerebrovascular event after cisplatin-basad chemotherapy for testicular cancer. Lancet 1991: 338:385-386
19. Içli F, Karaouz H, Dinçol D, Demirkazik A. Günel N, Karao uz R, et al. Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 1993; 72:587-593
20. Osawa T, Sugishita K, Murakumo M, Koyanagi T. [Case of brain infarction during cisplatin-based combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer] [Article in Japanese]. Nippon Hinyokika Gakkai Zasshi 2009; 100:12-15
21. Brouha ME, Bloemendal HJ, Kappelle LJ, Winter JB. [Cerebral infarction and myocardial infarction due to cisplatin-containing chamotherapy] [Article to Dutch]. Ned Tijdschr Geneeskd 2003; 147:457-460
22. Santos AJ, Malheiros SM. Borges LR, Dzik C, Nalli DG, Gabbai AA. [Ischemic stroke after chemotherapy with cisplatin, etoposide and bleomycin: case report] [Article in Portuguese]. Arq Neuropsiquiatr 2003; 61:129-133
23. Karagoz B, Bilgi O, Akyol I, Ozgun A, Turken O, Kandemir EG. Cerebrovascular accident after chamotherapy for testicular cancer. Mil Med 2009; 174:320-321
24. Lee AY. Thrombosis and cancer: the role of screening for occult cancer and recognizing the underlying biological mechanisms. Hematology Am Soc Hematol Educ Program 2006: 438-443
25. Stefenelli T, Kuzmits R, Ulrich W, Glogar D. Acute vascular toxicity after combination chamotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer. Eur Heart J 1988; 9:552-556
26. Bashir H, Crom D, Metzger M. Mulcahey J, Jones D, Hudson MM. Cisplatin-induced hypomagnesemia and cardiac dysrhythmia. Pediatr Blood Cancer 2007; 49:867-869
27. Tassinari D, Sartori S, Drudi G, Panzini I, Gianni L., Pasquini E, et al. Cardiac arrhythmias after cisplatin infusion: three case reports and a review of the literature. Ann Oncol 1997; 8:1263-1267,
28. Nuver J, Smit AJ, van der Meer J, van den Berg MP, van der Graaf WT, Meinardi MY, et al. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 2005; 23:9130-9137,
29. Licciardello JT. Moake JL. Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42:296-300.
30. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768-774